✦ LIBER ✦

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

✍ Scribed by R. Ramasubbaiah; S.M. Perkins; J. Schilder; C. Whalen; C.S. Johnson; M. Callahan; T. Jones; G. Sutton; D. Matei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I/II Study of Topotecan in Combi

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Phase II study of weekly topotecan in pa

✍ Tally Levy; Moshe Inbar; Joseph Menczer; Dan Grisaru; Marek Glezerman; Tamar Saf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Weekly combination of topotecan and gemc

✍ F. Joly; T. Petit; P. Pautier; E. Guardiola; F. Mayer; A. Chevalier-Place; R. De 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 403 KB

A phase II study of combined VEGF inhibi

✍ Mina, Lida A.; Yu, Menggang; Johnson, Cynthia; Burkhardt, Cyndi; Miller, Kathy D 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 112 KB

A phase II study of weekly topotecan and

✍ Divya Gupta; Ricky L. Owers; Mimi Kim; Dennis Yi-Shin Kuo; Gloria S. Huang; Shoh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Topotecan combined with carboplatin in r

✍ Heeseok Kang; Tae-Joong Kim; Yoo-Young Lee; Chel Hun Choi; Jeong-Won Lee; Duk-So 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB